Maynard Um
-
-
-
-
-
-
-
Zevra Therapeutics, Inc. (ZVRA) Tops Q2 EPS by 2c
-
-
-
-
-
-
-
H.C. Wainwright Assumes Zevra Therapeutics, Inc. (ZVRA) at Buy
-
-
-
-
-
-
-
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $18 at Citizens JMP
-
-
-
-
-
-
-
Zevra Therapeutics (ZVRA) to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale
-
-
-
-
-
-
-
Zevra Therapeutics (ZVRA) Halted, News Pending
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

